![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif)
| Vacuna en estudio para la prevención de la infección por el virus del papiloma humano y el cáncer de cuello uterino. La infección por ciertos tipos de VPH aumenta el riesgo de contraer cáncer de cuello uterino. También se llama vacuna contra el virus del papiloma humano. |
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081031094532im_/http://www.cancer.gov/images/spacer.gif) |